Texas City Joins Growing List of Municipalities Securing Access to Sensitive Data with BIO-key's PortalGuard Identity and Access Management Platform
April 13 2022 - 7:56AM
BIO-key International, Inc. (NASDAQ: BKYI), an
innovative provider of workforce and customer identity and access
management (IAM) solutions featuring Identity-Bound Biometrics
(IBB), today announced that a Texas city has selected its
PortalGuard IAM platform, with support for a broad array of
multi-factor authentication (MFA) options, to protect its
enterprise applications and data. Leveraging the PortalGuard IAM
platform, the municipality can strengthen its overall security
posture and effectively respond to evolving cyber threats. This new
customer relationship, BIO-key’s first with a Texas municipality,
was secured by Dallas-based IT consulting firm Mejeticks through
BIO-key’s master agent Intelisys.
Cyber-attacks against municipalities have
increased significantly in the last year, not only for monetary
profit but also to disrupt critical infrastructure, with school
districts, city halls, and police departments among the most
vulnerable. Today, the biggest cyber threat faced by municipalities
is ransomware that denies access to their files, computers, or
various secure data until an often-egregious ransom is paid. In
2022, municipalities have become the focal point of state-sponsored
hackers and cybercriminals seeking big payoffs and even more
significant media coverage to support their malicious enterprises.
Municipalities require robust, proven IAM solutions that can adapt
to various secure access requirements successfully and
cost-effectively.
BIO-key’s security team developed the
PortalGuard IAM platform to provide cost-effective IAM security
capabilities and benefits to its customers. This Texas-based
municipality selected PortalGuard through a competitive procurement
process, based on the solution’s comprehensive IAM capabilities and
flexibility to apply appropriate security policies to a variety of
user access scenarios. An essential element identified in the
municipality’s decision-making process was support for numerous MFA
options, including Identity-Bound Biometrics that validate the
user's identity - not just the device - to access sensitive data.
PortalGuard will significantly improve user access security by
providing the city's IT team the ability to manage different
methods of MFA security policies for all users. Importantly,
PortalGuard does not require users’ phones to be a primary second
factor, eliminating the security and privacy risks related to
personal phones.
"As IT security becomes more strategic and
critical to an organization's effectiveness, companies are looking
to accelerate deployment of advanced security solutions, while also
reducing IT costs and complexity," said Robert DeVita, CEO and
Founder, Mejeticks. "The PortalGuard solution delivers immediate
value to our customers by providing a more secure, predictable, and
scalable solution versus other competitive alternatives. Through
our relationship with Intelisys, we look forward to a long
partnership with BIO-key providing best-of-breed security benefits
to our customers."
"Increasing numbers of municipalities and local
government offices worldwide have reported significant data losses
due to municipal cyber-attacks which can have far greater
repercussions than similar attacks on an individual company's IT
assets," said Mark Cochran, President of BIO-key – PortalGuard. "In
partnership with Mejeticks and master agent Intelisys, we are
uniquely positioned in the cyber security market to offer
municipalities a comprehensive IAM security feature set."
About Mejeticks
(www.mejeticks.com)Mejeticks
is an IT Advisory and Consulting firm with over 20 years of
experience in helping Enterprise Customers with Network, Voice,
Cloud, and Data Center vendor selection. With a broad offering of
Technology solutions from over 250 providers, Mejeticks serves as a
trusted advisor to our enterprise clients in the areas of Unified
Communications (UCAAS), Network, Infrastructure as a Service
(IAAS), Data Center, and Security solutions and help them transform
their business to compete in today's expanding digital world.
Mejeticks is proud to be powered by Intelisys.
About BIO-key International, Inc.
(www.BIO-key.com)BIO-key
has over two decades of expertise in providing authentication
technology for thousands of organizations and millions of users and
is revolutionizing authentication with biometric-centric,
multi-factor identity and access management (IAM) solutions,
including its PortalGuard IAM solution that provides convenient and
secure access to devices, information, applications, and high-value
transactions. BIO-key's patented software and hardware solutions,
with industry-leading biometric capabilities, enable large-scale
on-premises and cloud-based Identity-as-a-Service (IDaaS)
solutions, as well as customized enterprise solutions.
BIO-key Safe Harbor
StatementAll statements contained in this press release
other than statements of historical facts are "forward-looking
statements" as defined in the Private Securities Litigation Reform
Act of 1995 (the "Act"). The words "estimate," "project,"
"intends," "expects," "anticipates," "believes," and similar
expressions are intended to identify forward-looking statements.
Such forward-looking statements are made based on management's
beliefs, as well as assumptions made by, and information currently
available to, management pursuant to the "safe harbor" provisions
of the Act. These statements are not guarantees of future
performance or events and are subject to risks and uncertainties
that may cause actual results to differ materially from those
included within or implied by such forward-looking statements.
These risks and uncertainties include, without limitation, our
history of losses and limited revenue; our ability to raise
additional capital; our ability to protect our intellectual
property; changes in business conditions; changes in our sales
strategy and product development plans; changes in the marketplace;
continued services of our executive management team; security
breaches; competition in the biometric technology industry; market
acceptance of biometric products generally and our products under
development; the duration and severity of the current coronavirus
COVID-19 pandemic and its effect on our business operations, sales
cycles, personnel, and the geographic markets in which we operate;
delays in the development of products and statements of assumption
underlying any of the foregoing as well as other factors set forth
under the caption see "Risk Factors'' in our Annual Report on Form
10-K for the year ended December 31, 2021 and other filings with
the Securities and Exchange Commission. Readers are cautioned not
to place undue reliance on these forward-looking statements, which
speak only as of the date made. Except as required by law, the
Company undertakes no obligation to disclose any revision to these
forward-looking statements whether as a result of new information,
future events, or otherwise. Additionally, there may be other
factors of which the Company is not currently aware that may affect
matters discussed in forward-looking statements and may also cause
actual results to differ materially from those discussed. In
particular, the consequences of the coronavirus outbreak to
economic conditions and the industry in general and the financial
position and operating results of our Company, in particular, have
been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key: |
|
Facebook – Corporate: |
https://www.facebook.com/BIOkeyInternational/ |
LinkedIn – Corporate: |
https://www.linkedin.com/company/bio-key-international |
Twitter – Corporate: |
@BIOkeyIntl |
Twitter – Investors: |
@BIO_keyIR |
StockTwits: |
BIO_keyIR |
BIO-key Media Contact:Erin Knapp Matter
Communications BIO-key@matternow.com 914-260-3158
Investor Contacts:William Jones, David
CollinsCatalyst IRBKYI@catalyst-ir.com212-924-9800
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Aug 2024 to Sep 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Sep 2023 to Sep 2024